Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in hea...

por Jenkins, H, Sakurai, Y, Nishimura, A, Okamoto, H, Hibberd, M, Jenkins, R, Yoneyama, T, Ashida, K, Ogama, Y, Warrington, S
Publicado 2015